Daktari Diagnostics, Inc. — Form D/A
Daktari Diagnostics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2014-04-07. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-07
- Form: D/A
- Accession: 0001470342-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 27
- Date of first sale: 2013-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-196384
Issuer
- Name: Daktari Diagnostics, Inc.
- CIK: 0001470342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 85 BOLTON STREET, CAMBRIDGE, MA, 02140
- Phone: 617-336-3299
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Christopher Earl | Director | Cambridge, MA |
| Roger Kitterman | Director | Boston, MA |
| Stanley Lapidus | Director | BOSTON, MA |
| Aaron Sandoski | Director | Bedford, MA |
| David Rubin | Director | Ann Arbor, MI |
| Michael Crowley | Executive Officer | Traverse City, MI |
| William Rodriguez | Director | Miami, FL |
| William Rodriguez | Executive Officer | Miami, FL |
| Thierry Bernard | Director | Bedford, MA |
| Edward Roberts | Director | Milford, NH |
| Peter Kaspar | Director | Cambridge, MA |
| Donald Hawthorne | Director | Cambridge, MA |
| Donald Hawthorne | Executive Officer | Cambridge, MA |
Other filings by this issuer (8)
More